Robert James Wills's Net Worth
-$516 Thousand
Who is Robert James Wills?
Robert James Wills does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., Milestone Pharmaceuticals Inc., and Oncternal Therapeutics, Inc..
SEC CIK
Robert James Wills's CIK is 0001634189
Past Insider Trading and Trends
2017 was Robert James Wills's most active year for acquiring shares with 8 total transactions. Robert James Wills's most active month to acquire stocks was the month of May. 2024 was Robert James Wills's most active year for disposing of shares, totalling 15 transactions. Robert James Wills's most active month to dispose stocks was the month of February. 2016 saw Robert James Wills paying a total of $226,216.86 for 657,456 shares, this is the most they've acquired in one year. In 2024 Robert James Wills cashed out on 363,440 shares for a total of $8,859.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CymaBay Therapeutics, Inc. (CBAY) No price found
InvestorRobert James Wills used to own units in Common Stock but no longer holds any shares there. In the year 2024 Robert James Wills filed a total of 17 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.00K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
| +20.00% | 5K |
$6.84 | $34,220.70 | 30K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
∞
| 25K |
$2.43 | $60,857.50 | 25K |
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.46
InvestorRobert James Wills owns 15,000 units of Common Shares which is worth $21,900.00. From 2020 to 2024 Robert James Wills acquired a total of 15,000 shares in Milestone Pharmaceuticals Inc. at a cost of $73,950.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 15K |
$4.93 | $73,950.00 | 15K |
Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47
Executive ChairmanRobert James Wills owns 10,000 units of Common Stock which is worth $44,700.00. From 2015 to 2024 Robert James Wills acquired a total of 1,338,456 shares in Oncternal Therapeutics, Inc. at a cost of $422,701.50, Robert also disposed a total of 980 shares of Oncternal Therapeutics, Inc. equalling to $8,859.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +44.63% | 3.09K |
$8.96 | $27,654.57 | 10K |
Apr 8
| |||
Form 4
|
∞
| 6.91K |
$8.48 | $58,602.37 | 6.91K |
Mar 28
| |||
Form 4
| -100.00% | -980.00 |
$9.04 | -$8,859.20 |
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
| +3.78% | 5K |
$16.75 | $83,750.00 | 137.34K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +10.29% | 123.46K |
$0.81 | $99,999.36 | 1.32M |
Oct 14
| |||
Form 4
| +9.09% | 100K |
$0.65 | $65,360.00 | 1.2M |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +85.67% | 46.14K |
$0.96 | $44,247.20 | 100K |
May 13 - May 14
| |||
Form 4
| +7.72% | 3.86K |
$0.80 | $3,088.00 | 53.86K |
May 11
| |||
Form 4
|
∞
| 50K |
$0.80 | $40,000.00 | 50K |
May 8
| |||
Form 4
|
∞
| 1M |
—
|
—
| 1M |
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||